Data Availability
The data included in this article is available from the corresponding author on reasonable request.
References
Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing’s syndrome. The Lancet. 2015;386:913–27. https://doi.org/10.1016/s0140-6736(14)61375-1.
Isidori AM, Sbardella E, Zatelli MC, Boschetti M, Vitale G, Colao A, et al. Conventional and nuclear medicine imaging in ectopic Cushing’s syndrome: a systematic review. J Clin Endocrinol Metab. 2015;100:3231–44. https://doi.org/10.1210/JC.2015-1589.
Elin P, Frederik C, Térence T, Michel K, Kim S, Lennert B, et al. 18F-AlF-NOTA-octreotide outperforms 68Ga-DOTATATE/NOC PET in neuroendocrine tumor patients: results from a prospective, multicenter study. J Nucl Med. 2023;64:632. https://doi.org/10.2967/jnumed.122.264563.
Boeckxstaens L, Pauwels E, Vandecaveye V, Deckers W, Cleeren F, Dekervel J, et al. Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients. EJNMMI Res. 2023;13:53. https://doi.org/10.1186/s13550-023-01003-3.
Long T, Yang N, Zhou M, Chen D, Li Y, Li J, et al. Clinical application of 18F-AlF-NOTA-octreotide PET/CT in combination with 18F-FDG PET/CT for imaging neuroendocrine neoplasms. Clin Nucl Med. 2019;44:452–8. https://doi.org/10.1097/RLU.0000000000002578.
Roya M, Mostafapour S, Mohr P, Providencia L, Li Z, van Snick JH, et al. Current and future use of long axial field-of-view positron emission tomography/computed tomography scanners in clinical oncology. Cancers. 2023;15. https://doi.org/10.3390/cancers15215173.
Funding
This study was supported by the Fundamental Research Funds for the Central Universities.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Consent to participate
Informed consent was obtained from individual participant included in the study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, L., Zhang, Y., Jin, C. et al. [18F]F-AlF-NOTA-octreotide PET/CT detected the [18F]FDG negative ectopic ACTH tumor in mediastinum. Eur J Nucl Med Mol Imaging 51, 1792–1793 (2024). https://doi.org/10.1007/s00259-024-06613-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-024-06613-0